tradingkey.logo

Metagenomi Inc

MGX
1.540USD
+0.130+9.22%
종가 02/06, 16:00ET시세는 15분 지연됩니다
57.82M시가총액
손실P/E TTM

Metagenomi Inc

1.540
+0.130+9.22%

자세한 내용은 Metagenomi Inc 회사

Metagenomi, Inc. is a precision genetic medicine company. The Company is focused on developing curative therapeutics for patients using its comprehensive metagenomics derived toolbox. Its diverse and modular genome editing toolbox is designed to precisely target any site in the human genome. Its comprehensive genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs). It has also developed a modular toolbox of genome editing systems that will allow it to interact with the human genome in a site-specific manner, where each tool can be matched to specific disease targets. The Company uses artificial intelligence and its metagenomics platform to develop curative genetic medicines.

Metagenomi Inc 정보

종목 코드 MGX
회사 이름Metagenomi Inc
상장일Feb 09, 2024
CEOIrish (Jian)
직원 수202
유형Ordinary Share
회계 연도 종료Feb 09
주소5959 Horton St
도시EMERYVILLE
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호94608
전화15108714880
웹사이트https://metagenomi.co/
종목 코드 MGX
상장일Feb 09, 2024
CEOIrish (Jian)

Metagenomi Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Co-Founder, Director
Co-Founder, Director
2.36M
-3830.00%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
824.33K
+246898.00%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-5239.00%
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Dr. Willard H. Dere, M.D.
Dr. Willard H. Dere, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
--
--
,
,
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
--
--
Mr. Laurence E. Reid, Ph.D.
Mr. Laurence E. Reid, Ph.D.
Director
Director
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Co-Founder, Director
Co-Founder, Director
2.36M
-3830.00%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
824.33K
+246898.00%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-5239.00%
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Dr. Willard H. Dere, M.D.
Dr. Willard H. Dere, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--

수익 분석

기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.

주식 보유 통계

마지막 업데이트: Sun, Feb 1
마지막 업데이트: Sun, Feb 1
주주
주주 유형
주주
주주
비율
Bayer HealthCare LLC
10.79%
Thomas (Brian C)
6.29%
Humboldt Capital, LLC
5.05%
The Vanguard Group, Inc.
3.38%
Bernales (Sebastian Ph.D.)
3.12%
기타
71.36%
주주
주주
비율
Bayer HealthCare LLC
10.79%
Thomas (Brian C)
6.29%
Humboldt Capital, LLC
5.05%
The Vanguard Group, Inc.
3.38%
Bernales (Sebastian Ph.D.)
3.12%
기타
71.36%
주주 유형
주주
비율
Corporation
15.85%
Individual Investor
12.68%
Investment Advisor
7.31%
Hedge Fund
3.18%
Venture Capital
3.00%
Investment Advisor/Hedge Fund
1.77%
Research Firm
1.39%
Sovereign Wealth Fund
0.67%
기타
54.14%

기관 주식 보유

마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
166
6.70M
17.86%
-8.85M
2025Q3
156
7.24M
19.30%
-9.50M
2025Q2
159
20.26M
54.19%
-7.71M
2025Q1
157
20.44M
54.67%
-7.64M
2024Q4
143
21.51M
57.48%
-2.78M
2024Q3
116
23.74M
63.40%
-1.13M
2024Q2
94
26.05M
69.54%
+4.67M
2024Q1
65
26.68M
71.20%
+16.22M

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Bayer HealthCare LLC
4.05M
10.79%
--
--
Sep 30, 2024
Thomas (Brian C)
2.36M
6.29%
-3.83K
-0.16%
Dec 05, 2025
Humboldt Capital, LLC
1.90M
5.05%
--
--
Apr 14, 2025
The Vanguard Group, Inc.
1.24M
3.31%
-16.13K
-1.28%
Sep 30, 2025
Bernales (Sebastian Ph.D.)
1.17M
3.12%
--
--
Apr 14, 2025
Irish (Jian)
824.33K
2.2%
+246.90K
+42.76%
Dec 05, 2025
Sozo Ventures LLC
581.58K
1.55%
--
--
Sep 30, 2025
Catalio Capital Management, LP
528.99K
1.41%
--
--
Sep 30, 2025
Peapod Lane Capital LLC
513.82K
1.37%
+5.71K
+1.12%
Sep 30, 2025
Millennium Management LLC
310.69K
0.83%
-72.34K
-18.89%
Sep 30, 2025
더 보기

관련 ETF

마지막 업데이트: Tue, Dec 2
마지막 업데이트: Tue, Dec 2
이름
비율
iShares Micro-Cap ETF
0.01%
Avantis US Small Cap Equity ETF
0%
iShares Russell 2000 Value ETF
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 ETF
0%
Schwab U.S. Small-Cap ETF
0%
iShares Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 Growth ETF
0%
iShares Micro-Cap ETF
비율0.01%
Avantis US Small Cap Equity ETF
비율0%
iShares Russell 2000 Value ETF
비율0%
Proshares Ultra Russell 2000
비율0%
ProShares Hedge Replication ETF
비율0%
Global X Russell 2000 ETF
비율0%
Schwab U.S. Small-Cap ETF
비율0%
iShares Russell 2000 ETF
비율0%
ProShares UltraPro Russell2000
비율0%
iShares Russell 2000 Growth ETF
비율0%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI